胰腺神经内分泌瘤的新治疗选择:叙述性审查
Agnieszka Romanowicz1, Marta Fudalej1,2, Alicja Asendrych-Woźniak1
1Department of Oncology, National Medical Institute of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.
Cancers
|December 11, 2025
概括
胰腺神经内分泌瘤 (PanNENs) 是各种癌症. 本综述涵盖了当前和新兴的系统性治疗先进的PanNETs,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
背景情况:
- 胰腺神经内分泌瘤 (PanNENs) 是一组异质的瘤.
- 大多数泛网是非功能性的,表达体静止素受体 (SSTR).
- 对于晚期PanNETs的最佳治疗顺序仍在研究中.
研究的目的:
- 审查当前针对高级泛网系统疗法的现有系统疗法.
- 讨论泛网的新和新兴的治疗策略.
主要方法:
- 对PanNETs的既定和正在研究的治疗方法的文献综述.
- 讨论包括向治疗和免疫治疗在内的全身治疗选择.
主要成果:
- 对于高级的PanNETs存在几种治疗选择,但没有定义最佳序列.
- 新的治疗药物正在开发中,包括免疫检查点抑制剂和下一代受体放射性核酸治疗.
结论:
- 多学科的方法对于评估泛网系统性治疗选择至关重要.
- 目前正在进行的临床试验和对新药的研究旨在改善高级PanNETs的结果.
相关概念视频
01:29Chronic Pancreatitis II: Collaborative Care
286
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
286
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
518
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
518
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K